Abstract
Ticarcillin disodium salt, also known as ticarcillin, is a semisynthetic, extended-spectrum beta-lactam antibiotic belonging to the carboxypenicillin class. This study aims to provide a comprehensive overview of ticarcillin disodium salt's pharmacological properties, including its mechanism of action, spectrum of activity, clinical applications, and potential side effects. Through a thorough review of available literature and recent research, this article seeks to elucidate the unique attributes of ticarcillin disodium salt in modern antimicrobial therapy.
We provide Ticarcillin Disodium Salt CAS 4697-14-7, please refer to the following website for detailed specifications and product information.
Introduction
Ticarcillin disodium salt was first developed by Beecham Plc (now part of GlaxoSmithKline) and introduced into clinical practice in 1977. It is a derivative of ticarcillin, which is characterized by its broad-spectrum activity against both gram-positive and gram-negative bacteria. As a beta-lactam antibiotic, ticarcillin disrupts bacterial cell wall synthesis by inhibiting the formation of peptidoglycan, an essential component of the bacterial cell wall. This mechanism of action leads to cell lysis and eventual bacterial death.
|
|
|
Chemical Structure and Properties
Ticarcillin disodium salt has the chemical formula C15H14N2Na2O6S2 and a molecular weight of 428.39 g/mol. It exists as a white or yellowish crystalline powder that is soluble in water. The chemical structure of ticarcillin incorporates a beta-lactam ring, a thiophene ring, and a carboxylic acid group, which contribute to its antibacterial activity. The disodium salt form enhances its water solubility and facilitates parenteral administration.
Mechanism of Action
Ticarcillin disodium salt exerts its antibacterial activity by inhibiting the synthesis of peptidoglycan, a critical component of the bacterial cell wall. This inhibition occurs through the binding of ticarcillin to penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell. PBPs are enzymes involved in the cross-linking of peptidoglycan chains, which provides structural rigidity to the bacterial cell wall. By binding to PBPs, ticarcillin disrupts the normal process of cell wall synthesis, leading to cell wall weakness and eventual lysis.
Spectrum of Activity
Ticarcillin disodium salt demonstrates a broad spectrum of activity against both gram-positive and gram-negative bacteria. However, it is particularly effective against gram-negative organisms, including Pseudomonas aeruginosa, a common cause of nosocomial infections. In vitro studies have shown that ticarcillin is more active than carbenicillin against Pseudomonas but less active than piperacillin. Additionally, ticarcillin is active against a variety of other gram-negative bacteria, such as Escherichia coli, Klebsiella pneumoniae, and Enterobacter species.
Against gram-positive bacteria, ticarcillin demonstrates activity against streptococci, staphylococci, and some anaerobic organisms. However, it is generally less effective than other antibiotics, such as penicillin G, against gram-positive infections. The broad spectrum of activity of ticarcillin disodium salt makes it a valuable option for the treatment of a wide range of infections, including lower respiratory tract infections, skin and skin structure infections, urinary tract infections, and intra-abdominal infections.
Pharmacokinetics
Ticarcillin disodium salt is primarily administered parenterally, either intravenously or intramuscularly. After administration, ticarcillin is rapidly distributed throughout the body, with high concentrations achieved in tissues and body fluids, including the interstitial fluid, bile, and urine. The plasma protein binding of ticarcillin is approximately 60%, and it has a volume of distribution of 0.16-0.28 L/kg.
Ticarcillin undergoes minimal metabolism in the body and is primarily excreted unchanged in the urine via glomerular filtration. The elimination half-life of ticarcillin is approximately 1 hour, and it is primarily cleared by renal mechanisms. In patients with renal impairment, the elimination half-life may be prolonged, and dosage adjustments may be necessary to prevent toxicity.
|
|
|
Clinical Applications
Ticarcillin disodium salt is commonly used in the treatment of a variety of bacterial infections, including lower respiratory tract infections, skin and skin structure infections, urinary tract infections, intra-abdominal infections, and bacterial sepsis. Its broad spectrum of activity and favorable pharmacokinetic properties make it a valuable option for both empiric and targeted therapy.
In the treatment of lower respiratory tract infections, ticarcillin disodium salt is often used in combination with other antibiotics, such as clavulanic acid, to broaden its spectrum of activity and enhance its efficacy against penicillin-resistant organisms. Similarly, in the treatment of intra-abdominal infections, ticarcillin may be combined with an aminoglycoside or a fluoroquinolone to provide synergistic activity against a broader range of pathogens.
Adverse Effects and Precautions
Ticarcillin disodium salt is generally well-tolerated, but it can cause a range of adverse effects, including nausea, vomiting, diarrhea, and rash. More severe adverse effects, such as anaphylactic reactions and superinfections, are rare but can occur. As with all beta-lactam antibiotics, ticarcillin should be used cautiously in patients with a history of penicillin allergy.
Ticarcillin disodium salt should also be used with caution in patients with renal impairment, as dosage adjustments may be necessary to prevent toxicity. In addition, ticarcillin should not be used in patients with a history of severe hypersensitivity reactions to any component of the formulation.
Drug Interactions
Ticarcillin disodium salt may interact with a variety of other drugs, including probenecid, which can reduce the renal clearance of ticarcillin and increase the risk of toxicity. Concomitant use of ticarcillin with aminoglycosides may increase the risk of nephrotoxicity. Therefore, close monitoring of renal function is recommended when these drugs are used in combination.
Ticarcillin disodium salt may also interact with anticoagulants, such as warfarin, by inhibiting platelet aggregation and increasing the risk of bleeding. Therefore, patients receiving ticarcillin and anticoagulants should be closely monitored for signs of bleeding.
Conclusion
Ticarcillin disodium salt is a valuable antibiotic with a broad spectrum of activity against both gram-positive and gram-negative bacteria. Its favorable pharmacokinetic properties and clinical efficacy make it a suitable option for the treatment of a wide range of infections. However, like all antibiotics, ticarcillin should be used judiciously to prevent the emergence of resistant organisms. Close monitoring of patients for adverse effects and drug interactions is essential to ensure safe and effective use of ticarcillin disodium salt in clinical practice.
Future Directions
Further research is needed to investigate the role of ticarcillin disodium salt in the treatment of emerging resistant organisms and to develop new formulations that may enhance its efficacy and reduce the risk of adverse effects. Additionally, studies are needed to evaluate the potential for ticarcillin to be used in combination with other antibiotics to provide synergistic activity against a broader range of pathogens.
In conclusion, ticarcillin disodium salt is a versatile antibiotic with a broad spectrum of activity that continues to play an important role in the treatment of bacterial infections. With continued research and careful clinical management, ticarcillin disodium salt will remain a valuable option in the antimicrobial arsenal for the foreseeable future.